SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology
February 1, 2024
SeaStar Medical Holding Corporation (Nasdaq: ICU) announces the issuance by the Canadian Intellectual Property Office of Canadian Patent No. 2814586